Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis()

BACKGROUND/AIMS: Angiotensin-converting enzyme 2 (ACE2), its product, angiotensin-(1–7) and its receptor, Mas, may moderate the adverse effects of angiotensin II in liver disease. We examined the expression of these novel components of the renin angiotensin system (RAS) and the production and vasoac...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Hepatol
Main Authors: Herath, Chandana B., Warner, Fiona J., Lubel, John S., Dean, Rachael G., Jia, Zhiyuan, Lew, Rebecca A., Smith, A. Ian, Burrell, Louise M., Angus, Peter W.
Formato: Artigo
Idioma:Inglês
Publicado: European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. 2007
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7114685/
https://ncbi.nlm.nih.gov/pubmed/17532087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2007.03.008
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares